ライフサイエンス出版株式会社

FacebookTwitterInstagram
menu

Japan Society of Clinical Trials and Research ( JPT Supplement )

Vol. 46 Suppl. 1 2018

■REVIEW Countermeasures for “Clinical Trials Act”

Point of “Clinical Trials Act”

H. Ohtsu

Jpn Pharmacol Ther 2018 46(s1) s6


Subsequent Events of Results of the Questionnaire about Clinical Trials Act that Members of the Japan Society of Clinical Trials and Research Replied

H. Taruno

Jpn Pharmacol Ther 2018 46(s1) s9


The Handbook Dealing with Clinical Trials Act for Principal Investigators

Y.Ohashi and H. Taruno

Jpn Pharmacol Ther 2018 46(s1) s14


How Do We Manage the Clinical Research Act as Academia?
Shine a Light on “the Elephant in the Dark”

H. Yamamoto

Jpn Pharmacol Ther 2018 46(s1) s19


How Do We Cope with the Clinical Research Act as a Multicenter Clinical Trial Group?

K.Nakamura

Jpn Pharmacol Ther 2018 46(s1) s23